Navigation Links
USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
Date:2/27/2009

UPLC/Tandem Quadrupole Mass Spectrometry System Intended for Veterinary Drug Residue Analysis of Poultry and Livestock

MILFORD, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the United States Department of Agriculture's Agricultural Research Service has purchased a Waters(R) ACQUITY(R) TQD System to develop rapid and accurate test methods for screening poultry and beef for trace concentrations of veterinary drug residues. The instrument purchased is for the USDA's Wyndmoor, Pa. research laboratory.

Farm-raised poultry and livestock often receive drugs to protect them from disease and promote their growth. Through ignorance, carelessness or deceit on the part of a small number of producers, poultry and livestock that enter the food chain can contain banned substances or legal drugs at concentrations that exceed maximum allowable levels. The need to obtain more information from a single injection is underscored by increasing demands on laboratory time and resources for reproducible, highly-accurate and precise results on larger numbers of samples.

Analytical methods that employ UltraPerformance Liquid Chromatography (UPLC(R)) coupled with tandem mass spectrometry can screen for more than 100 different drug residues at a time at concentrations of less than 10 ng/mL, a big improvement in speed, efficiency, and sensitivity over the traditional seven-plate bioassay method.

The USDA chose Waters ACQUITY TQD System based on criteria for a UPLC/MS/MS system with a tandem quadrupole mass spectrometry detector capable of 20 millisecond positive and negative switching, a feature deemed highly-important for multi-analyte detection of both positively and negatively-charged compounds in a single analytical run.

Waters ACQUITY TQD System features the Waters ACQUITY UltraPerformance LC(R) System (UPLC(R)), a tandem quadrupole (TQ) mass detector, ACQUITY BEH analytical columns, all operated under Waters MassLynx(TM) 4.1 Mass Spectrometry Software. The MassLynx Software includes TargetLynx(TM) software for targeted analyte quantification and the QuanOptimise(TM) feature for automated system optimization and method development. This UPLC/MS/MS system operates with 1.7 micron ACQUITY BEH Columns and is a true UPLC system for measuring concentrations of veterinary drug residues, pesticides, and other contaminants in foods and beverages.

For More Information

More information on Waters ACQUITY TQD System, visit www.waters.com/tqd. For more information on Waters entire portfolio of LC/MS/MS products, please visit: http://www.waters.com/ms.

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, UltraPerformance LC, UPLC, ACQUITY, MassLynx, QuanOptimise, and TargetLynx are trademarks of Waters Corporation.

    Contact:
    Brian J. Murphy
    Waters Corporation
    Public Relations Manager
    508-482-2614
    Brian_J_Murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. KanekaQH(TM) Ubiquinol Dramatically Boosts Ejection Fraction in Patients With Late-Stage Congestive Heart Failure
2. Winning University of Melbourne Ph.D. research boosts the search for sensitive sensors
3. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
4. On the boil: New nano technique significantly boosts boiling efficiency
5. Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management
6. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
7. New Scandinavian collaboration boosts nanotech development
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
10. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
11. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... ... academic medical centers. The network provides members nationally scaled infrastructure and support to ... and restrictive payer agreements so members can provide continuity of care for their ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... upon patented KBioBox technology, the extended GUIDE-Seq ananlysis. KBioBox has adapted their core ... to be provide scientists with easy to understand reports, extended indel analysis, and ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... The awards recognize medical centers that have implemented innovative products, services, and technology ... care protocols, competitive advantages, financial impact/value, and market need. The applicants with the ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):